Mark R Stenger1, Preeti Pathela, Greta Anschuetz, Heidi Bauer, Julieann Simon, Robert Kohn, Christina Schumacher, Elizabeth Torrone. 1. From the *Division of STD Prevention, US Centers for Disease Control & Prevention; †New York City Department of Health and Mental Hygiene, Bureau of STD Control, Queens, NY; ‡Philadelphia Department of Public Health, STD Control Program, Philadelphia, PA; §California Department of Public Health, STD Control Branch, Richmond, CA; ¶Washington State Department of Health, Olympia, WA; ∥San Francisco Department of Public Health, San Francisco, CA; and **Baltimore City Health Department & Johns Hopkins School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Inequalities in Neisseria gonorrhoeae (gonorrhea) burden by sexual minority status in the United States are difficult to quantify. Sex of sex partner is not routinely collected for reported cases. Population estimates of men who have sex with men (MSM) necessary to calculate case rates have not been available until recently. For these reasons, trends in reported gonorrhea rates among MSM have not been described across multiple jurisdictions. METHODS: We estimated of the number of MSM cases reported in 6 jurisdictions continuously participating in the STD Surveillance Network 2010-2015 based on interviews with a random sample of cases. Data were obtained for Baltimore, Philadelphia, New York City, San Francisco, California (excluding San Francisco), and Washington State. Estimates of the MSM, heterosexual male (MSW) and female populations were obtained from recently published estimates and census data. Case rates and rate-ratios were calculated comparing trends in reported cases among MSM, heterosexual males and women. RESULTS: The proportion of male gonorrhea cases among MSM varied by jurisdiction (range: 20% to 98%). Estimated MSM rate increased from 1369 cases per 100,000 in 2010 to 3435 cases per 100,000 in 2015. Between 2010 and 2015, the MSM-to-Women gonorrhea rate ratio increased from 13:1 to 24:1, and the MSM-to-MSW gonorrhea rate ratio increased from 16:1 to 31:1. CONCLUSIONS: Estimated gonorrhea rate among MSM increased in a network of 6 geographically diverse US jurisdictions. Estimating the size of this population, determining MSM among reported cases and estimating rates are essential first steps for better understanding the changing epidemiology of gonorrhea.
BACKGROUND: Inequalities in Neisseria gonorrhoeae (gonorrhea) burden by sexual minority status in the United States are difficult to quantify. Sex of sex partner is not routinely collected for reported cases. Population estimates of men who have sex with men (MSM) necessary to calculate case rates have not been available until recently. For these reasons, trends in reported gonorrhea rates among MSM have not been described across multiple jurisdictions. METHODS: We estimated of the number of MSM cases reported in 6 jurisdictions continuously participating in the STD Surveillance Network 2010-2015 based on interviews with a random sample of cases. Data were obtained for Baltimore, Philadelphia, New York City, San Francisco, California (excluding San Francisco), and Washington State. Estimates of the MSM, heterosexual male (MSW) and female populations were obtained from recently published estimates and census data. Case rates and rate-ratios were calculated comparing trends in reported cases among MSM, heterosexual males and women. RESULTS: The proportion of male gonorrhea cases among MSM varied by jurisdiction (range: 20% to 98%). Estimated MSM rate increased from 1369 cases per 100,000 in 2010 to 3435 cases per 100,000 in 2015. Between 2010 and 2015, the MSM-to-Womengonorrhea rate ratio increased from 13:1 to 24:1, and the MSM-to-MSW gonorrhea rate ratio increased from 16:1 to 31:1. CONCLUSIONS: Estimated gonorrhea rate among MSM increased in a network of 6 geographically diverse US jurisdictions. Estimating the size of this population, determining MSM among reported cases and estimating rates are essential first steps for better understanding the changing epidemiology of gonorrhea.
Authors: Robert D Kirkcaldy; Edward W Hook; Olusegun O Soge; Carlos del Rio; Grace Kubin; Jonathan M Zenilman; John R Papp Journal: JAMA Date: 2015-11-03 Impact factor: 56.272
Authors: Robert D Kirkcaldy; Akbar Zaidi; Edward W Hook; King K Holmes; King H Holmes; Olusegun Soge; Carlos del Rio; Geraldine Hall; John Papp; Gail Bolan; Hillard S Weinstock Journal: Ann Intern Med Date: 2013-03-05 Impact factor: 25.391
Authors: David W Purcell; Christopher H Johnson; Amy Lansky; Joseph Prejean; Renee Stein; Paul Denning; Zaneta Gau; Hillard Weinstock; John Su; Nicole Crepaz Journal: Open AIDS J Date: 2012-09-07
Authors: Jeremy A Grey; Kyle T Bernstein; Patrick S Sullivan; David W Purcell; Harrell W Chesson; Thomas L Gift; Eli S Rosenberg Journal: JMIR Public Health Surveill Date: 2016-04-21
Authors: Mark Stenger; Heidi Bauer; Ellen Klingler; Teal Bell; Jennifer Donnelly; Margaret Eaglin; Megan Jespersen; Robbie Madera; Melanie Mattson; Elizabeth Torrone Journal: Sex Transm Dis Date: 2018-03 Impact factor: 2.830
Authors: Emily J Weston; Robert D Kirkcaldy; Mark Stenger; Eloisa Llata; Brooke Hoots; Elizabeth A Torrone Journal: Sex Transm Dis Date: 2018-04 Impact factor: 2.830
Authors: Jeb Jones; Kevin Weiss; Jonathan Mermin; Patricia Dietz; Eli S Rosenberg; Thomas L Gift; Harrell Chesson; Patrick S Sullivan; Cynthia Lyles; Kyle T Bernstein; Samuel M Jenness Journal: Sex Transm Dis Date: 2019-06 Impact factor: 2.830
Authors: Emily R Learner; Kristen Kreisel; Robert D Kirkcaldy; Karen Schlanger; Elizabeth A Torrone Journal: Am J Public Health Date: 2020-03-19 Impact factor: 9.308
Authors: Dionne Gesink; Susan Wang; Tim Guimond; Lauren Kimura; James Connell; Travis Salway; Mark Gilbert; Sharmistha Mishra; Darrell Tan; Ann N Burchell; David J Brennan; Carmen H Logie; Daniel Grace Journal: Sex Transm Dis Date: 2018-06 Impact factor: 2.830
Authors: Sandra I McCoy; Raluca Buzdugan; Reva Grimball; Lauren Natoli; Christopher M Mejia; Jeffrey D Klausner; Mark R McGrath Journal: Mhealth Date: 2018-09-25